These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 38276512)

  • 1. A Bilayer Microarray Patch (MAP) for HIV Pre-Exposure Prophylaxis: The Role of MAP Designs and Formulation Composition in Enhancing Long-Acting Drug Delivery.
    Vora LK; Tekko IA; Zanutto FV; Sabri A; Choy RKM; Mistilis J; Kwarteng P; Jarrahian C; McCarthy HO; Donnelly RF
    Pharmaceutics; 2024 Jan; 16(1):. PubMed ID: 38276512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hydrogel-forming microarray patches with cyclodextrin drug reservoirs for long-acting delivery of poorly soluble cabotegravir sodium for HIV Pre-Exposure Prophylaxis.
    Volpe-Zanutto F; Vora LK; Tekko IA; McKenna PE; Permana AD; Sabri AH; Anjani QK; McCarthy HO; Paredes AJ; Donnelly RF
    J Control Release; 2022 Aug; 348():771-785. PubMed ID: 35738464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and Evaluation of Dissolving Microarray Patches for Co-administered and Repeated Intradermal Delivery of Long-acting Rilpivirine and Cabotegravir Nanosuspensions for Paediatric HIV Antiretroviral Therapy.
    Moffatt K; Tekko IA; Vora L; Volpe-Zanutto F; Hutton ARJ; Mistilis J; Jarrahian C; Akhavein N; Weber AD; McCarthy HO; Donnelly RF
    Pharm Res; 2023 Jul; 40(7):1673-1696. PubMed ID: 36224503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intradermal delivery of the antiretroviral drugs cabotegravir and rilpivirine by dissolving microarray patches: Investigation of lymphatic uptake.
    Ramöller IK; Volpe-Zanutto F; Vora LK; Abbate MTA; Hutton ARJ; McKenna PE; Peng K; Tekko IA; Sabri A; McAlister E; McCarthy HO; Paredes AJ; Donnelly RF
    J Control Release; 2024 Feb; 366():548-566. PubMed ID: 38211640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physiologically Based Pharmacokinetic Modelling of Cabotegravir Microarray Patches in Rats and Humans.
    Kinvig H; Rajoli RKR; Pertinez H; Vora LK; Volpe-Zanutto F; Donnelly RF; Rannard S; Flexner C; Siccardi M; Owen A
    Pharmaceutics; 2023 Nov; 15(12):. PubMed ID: 38140050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modelling the intradermal delivery of microneedle array patches for long-acting antiretrovirals using PBPK.
    Rajoli RKR; Flexner C; Chiong J; Owen A; Donnelly RF; Larrañeta E; Siccardi M
    Eur J Pharm Biopharm; 2019 Nov; 144():101-109. PubMed ID: 31525446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 2-Hydroxypropyl-β-cyclodextrin-enhanced pharmacokinetics of cabotegravir from a nanofluidic implant for HIV pre-exposure prophylaxis.
    Pons-Faudoa FP; Sizovs A; Di Trani N; Paez-Mayorga J; Bruno G; Rhudy J; Manohar M; Gwenden K; Martini C; Chua CYX; Varchi G; Marzinke MA; Grattoni A
    J Control Release; 2019 Jul; 306():89-96. PubMed ID: 31136811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of Norelgestromin Dissolving Bilayer Microarray Patches for Sustained Release of Hormonal Contraceptive.
    Vora LK; Tekko IA; Volpe Zanutto F; Sabri A; Choy RKM; Mistilis J; Kwarteng P; Kilbourne-Brook M; Jarrahian C; McCarthy HO; Donnelly RF
    Pharmaceutics; 2024 Jul; 16(7):. PubMed ID: 39065643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydrogel-forming microarray patches with solid dispersion reservoirs for transdermal long-acting microdepot delivery of a hydrophobic drug.
    Naser YA; Tekko IA; Vora LK; Peng K; Anjani QK; Greer B; Elliott C; McCarthy HO; Donnelly RF
    J Control Release; 2023 Apr; 356():416-433. PubMed ID: 36878320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluating Islatravir Administered Via Microneedle Array Patch for Long-Acting HIV Pre-exposure Prophylaxis Using Physiologically Based Pharmacokinetic Modelling.
    Kinvig H; Cottura N; Lloyd A; Frivold C; Mistilis J; Jarrahian C; Siccardi M
    Eur J Drug Metab Pharmacokinet; 2022 Nov; 47(6):855-868. PubMed ID: 36178586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydrogel-forming microneedles for rapid and efficient skin deposition of controlled release tip-implants.
    Peng K; Vora LK; Domínguez-Robles J; Naser YA; Li M; Larrañeta E; Donnelly RF
    Mater Sci Eng C Mater Biol Appl; 2021 Aug; 127():112226. PubMed ID: 34225871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring user and stakeholder perspectives from South Africa and Uganda to refine microarray patch development for HIV PrEP delivery and as a multipurpose prevention technology.
    Ismail A; Magni S; Katahoire A; Ayebare F; Siu G; Semitala F; Kyambadde P; Friedland B; Jarrahian C; Kilbourne-Brook M
    PLoS One; 2023; 18(8):e0290568. PubMed ID: 37651432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, formulation and evaluation of novel dissolving microarray patches containing a long-acting rilpivirine nanosuspension.
    Mc Crudden MTC; Larrañeta E; Clark A; Jarrahian C; Rein-Weston A; Lachau-Durand S; Niemeijer N; Williams P; Haeck C; McCarthy HO; Zehrung D; Donnelly RF
    J Control Release; 2018 Dec; 292():119-129. PubMed ID: 30395897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formulation of two-layer dissolving polymeric microneedle patches for insulin transdermal delivery in diabetic mice.
    Lee IC; Lin WM; Shu JC; Tsai SW; Chen CH; Tsai MT
    J Biomed Mater Res A; 2017 Jan; 105(1):84-93. PubMed ID: 27539509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fully synthetic injectable depots with high drug content and tunable pharmacokinetics for long-acting drug delivery.
    Ho DK; LeGuyader C; Srinivasan S; Roy D; Vlaskin V; Chavas TEJ; Lopez CL; Snyder JM; Postma A; Chiefari J; Stayton PS
    J Control Release; 2021 Jan; 329():257-269. PubMed ID: 33217474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elucidating the Impact of Surfactants on the Performance of Dissolving Microneedle Array Patches.
    Anjani QK; Sabri AHB; Utomo E; Domínguez-Robles J; Donnelly RF
    Mol Pharm; 2022 Apr; 19(4):1191-1208. PubMed ID: 35235330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multilayered pyramidal dissolving microneedle patches with flexible pedestals for improving effective drug delivery.
    Lau S; Fei J; Liu H; Chen W; Liu R
    J Control Release; 2017 Nov; 265():113-119. PubMed ID: 27574991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel bilayer dissolving microneedle arrays with concentrated PLGA nano-microparticles for targeted intradermal delivery: Proof of concept.
    Vora LK; Donnelly RF; Larrañeta E; González-Vázquez P; Thakur RRS; Vavia PR
    J Control Release; 2017 Nov; 265():93-101. PubMed ID: 29037785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymeric Microarray Patches for Enhanced Transdermal Delivery of the Poorly Soluble Drug Olanzapine.
    McKenna PE; Abbate MTA; Vora LK; Sabri AH; Peng K; Volpe-Zanutto F; Tekko IA; Permana AD; Maguire C; Dineen D; Kearney MC; Larrañeta E; Paredes AJ; Donnelly RF
    ACS Appl Mater Interfaces; 2023 Jul; 15(26):31300-31319. PubMed ID: 37349320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel tip-loaded dissolving and implantable microneedle array patches for sustained release of finasteride.
    Paredes AJ; Volpe-Zanutto F; Permana AD; Murphy AJ; Picco CJ; Vora LK; Coulter JA; Donnelly RF
    Int J Pharm; 2021 Sep; 606():120885. PubMed ID: 34271153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.